Published in Vaccine Weekly, April 6th, 2011
"the parent strain PM14 expressed very low levels of SpaP-S1. By comparison, the dlt mutant strain, which has a mutation in the dlt operon preventing D-alanylation of the cell wall lipoteichoic acids, and another mutant strain,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly